PUBLISHER: The Business Research Company | PRODUCT CODE: 1825992
PUBLISHER: The Business Research Company | PRODUCT CODE: 1825992
Dengue Treatment Global Market Report 2025
Dengue treatment involves the medical management and supportive care for individuals infected with the dengue virus, which is transmitted by Aedes mosquitoes. The treatment primarily focuses on supportive care, such as managing fever with paracetamol, providing hydration through oral or intravenous fluids, and closely monitoring for complications such as bleeding or shock to ensure timely intervention and recovery.
The main types of dengue treatment include vaccines and acetaminophen. Vaccines are biological substances that trigger the body's immune system to provide immunity against specific diseases. These vaccines can be administered through various routes, including parenteral and oral. The key drug classes involved in dengue treatment include NSAIDs, antibiotics, and corticosteroids, which are distributed through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies. These treatments are used by a range of end users, including hospitals, specialty clinics, and home healthcare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The dengue treatment market research report is one of a series of new reports from The Business Research Company that provides dengue treatment market statistics, including dengue treatment industry global market size, regional shares, competitors with a dengue treatment market share, detailed dengue treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dengue treatment industry. This dengue treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dengue treatment market size has grown rapidly in recent years. It will grow from $2.1 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to improved diagnostic tools, government and NGO efforts, epidemiological surveillance systems, significant investments in r&d and community education initiatives.
The dengue treatment market size is expected to see rapid growth in the next few years. It will grow to $3.6 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to development of universal vaccines, expanding vaccine availability, public-private partnerships, telemedicine growth and policy framework enhancements. Major trends in the forecast period include next-generation dengue vaccines, AI-based drug discovery, smart contact tracing tools, 3D-printed vaccines and crispr for virus targeting.
The forecast of 11.3% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of NS1 antigen tests and investigational antivirals imported from India and Brazil, thereby delaying tropical disease management and elevating travel medicine costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of dengue is anticipated to drive the growth of the dengue treatment market in the future. Dengue is a mosquito-borne viral infection that causes flu-like symptoms and can lead to severe complications if left untreated. The rise in dengue cases is largely attributed to factors such as urbanization, climate change that favors mosquito breeding, insufficient vector control measures, and population growth in high-risk areas. Timely dengue treatment helps reduce the incidence rate by alleviating severe symptoms, preventing complications, and controlling the spread of the disease through improved patient outcomes and enhanced public health awareness. For example, in 2023, a report by the Centers for Disease Control and Prevention (CDC) highlighted that dengue fever cases in the Americas surged to over 4.6 million, with about 4,000 deaths, marking a 13% increase compared to 2022 and a significant rise from previous years. As a result, the increasing incidence of dengue is expected to fuel market growth in dengue treatment.
Key companies in the dengue treatment market are focusing on innovations such as broad-spectrum antiviral drugs to improve treatment efficacy, reduce disease severity, and address multiple serotypes of the dengue virus simultaneously. Broad-spectrum antiviral drugs are medications effective against a wide range of viruses, rather than targeting a specific one. For example, in September 2024, Hyundai Pharmaceutical Co. Ltd., a South Korea-based pharmaceutical company, launched XAFTY, an innovative broad-spectrum antiviral designed to treat multiple viral infections, including COVID-19 and dengue fever. XAFTY features an advanced drug formulation that improves the absorption and effectiveness of niclosamide, has demonstrated safety and efficacy in clinical trials, targets various RNA viruses, and provides versatility against potential future threats, along with the ability for rapid response in regions facing public health emergencies.
In February 2024, Takeda Pharmaceutical Company, a multinational pharmaceutical company based in Japan, collaborated with Biological E. Limited to enhance the production of its dengue vaccine, TAK-003. This partnership aims to increase the annual production of the vaccine to 50 million doses, ensuring sustainable access in dengue-endemic regions and advancing global efforts in dengue prevention. Biological E. Ltd is an India-based biotechnology company specializing in dengue treatment.
Major players in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited
Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dengue treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the dengue treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The dengue treatment market consists of sales of products including antipyretics, hydration solutions, blood products, nutritional supplements, diagnostic kits, and protective measures. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dengue Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dengue treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dengue treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dengue treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Vaccines; Acetaminophen
- 2) By Route Of Administration: Parenteral; Oral
- 3) By Drug Class: Nsaids; Antibiotics; Corticosteroids
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- 5) By End User: Hospital; Specialty Clinics; Home Healthcare
- Subsegments:
- 1) By Vaccines: Live Attenuated Vaccines; Recombinant Vaccines; Inactivated Vaccines
- 2) By Acetaminophen: Oral Acetaminophen; Intravenous Acetaminophen
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co Inc.; Sanofi S.A.; Abbott Laboratories; Novartis International AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Boehringer Ingelheim GmbH; Hetero Labs Limited; Sun Pharmaceutical Industries Limited; Dr. Reddy's Laboratories Limited; Cipla Incorporated; Emergent BioSolutions Inc.; Bharat Biotech International Limited; Inovio Pharmaceuticals Inc.; Gennova Biopharmaceuticals Ltd.; ABIVAX S.A.; Cadila Healthcare Limited; Biological E. Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Dengue Treatment Market Characteristics
3. Dengue Treatment Market Trends And Strategies
4. Dengue Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Dengue Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Dengue Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Dengue Treatment Market Growth Rate Analysis
- 5.4. Global Dengue Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Dengue Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Dengue Treatment Total Addressable Market (TAM)
6. Dengue Treatment Market Segmentation
- 6.1. Global Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Vaccines
- Acetaminophen
- 6.2. Global Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Parenteral
- Oral
- 6.3. Global Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nsaids
- Antibiotics
- Corticosteroids
- 6.4. Global Dengue Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.5. Global Dengue Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Specialty Clinics
- Home Healthcare
- 6.6. Global Dengue Treatment Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Live Attenuated Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
- 6.7. Global Dengue Treatment Market, Sub-Segmentation Of Acetaminophen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Acetaminophen
- Intravenous Acetaminophen
7. Dengue Treatment Market Regional And Country Analysis
- 7.1. Global Dengue Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Dengue Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Dengue Treatment Market
- 8.1. Asia-Pacific Dengue Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Dengue Treatment Market
- 9.1. China Dengue Treatment Market Overview
- 9.2. China Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Dengue Treatment Market
- 10.1. India Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Dengue Treatment Market
- 11.1. Japan Dengue Treatment Market Overview
- 11.2. Japan Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Dengue Treatment Market
- 12.1. Australia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Dengue Treatment Market
- 13.1. Indonesia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Dengue Treatment Market
- 14.1. South Korea Dengue Treatment Market Overview
- 14.2. South Korea Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Dengue Treatment Market
- 15.1. Western Europe Dengue Treatment Market Overview
- 15.2. Western Europe Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Dengue Treatment Market
- 16.1. UK Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Dengue Treatment Market
- 17.1. Germany Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Dengue Treatment Market
- 18.1. France Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Dengue Treatment Market
- 19.1. Italy Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Dengue Treatment Market
- 20.1. Spain Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Dengue Treatment Market
- 21.1. Eastern Europe Dengue Treatment Market Overview
- 21.2. Eastern Europe Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Dengue Treatment Market
- 22.1. Russia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Dengue Treatment Market
- 23.1. North America Dengue Treatment Market Overview
- 23.2. North America Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Dengue Treatment Market
- 24.1. USA Dengue Treatment Market Overview
- 24.2. USA Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Dengue Treatment Market
- 25.1. Canada Dengue Treatment Market Overview
- 25.2. Canada Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Dengue Treatment Market
- 26.1. South America Dengue Treatment Market Overview
- 26.2. South America Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Dengue Treatment Market
- 27.1. Brazil Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Dengue Treatment Market
- 28.1. Middle East Dengue Treatment Market Overview
- 28.2. Middle East Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Dengue Treatment Market
- 29.1. Africa Dengue Treatment Market Overview
- 29.2. Africa Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Dengue Treatment Market Competitive Landscape And Company Profiles
- 30.1. Dengue Treatment Market Competitive Landscape
- 30.2. Dengue Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
31. Dengue Treatment Market Other Major And Innovative Companies
- 31.1. Novartis International AG
- 31.2. GlaxoSmithKline plc
- 31.3. Takeda Pharmaceutical Company Limited
- 31.4. Boehringer Ingelheim GmbH
- 31.5. Hetero Labs Limited
- 31.6. Sun Pharmaceutical Industries Limited
- 31.7. Dr. Reddy's Laboratories Limited
- 31.8. Cipla Incorporated
- 31.9. Emergent BioSolutions Inc.
- 31.10. Bharat Biotech International Limited
- 31.11. Inovio Pharmaceuticals Inc.
- 31.12. Gennova Biopharmaceuticals Ltd.
- 31.13. ABIVAX S.A.
- 31.14. Cadila Healthcare Limited
- 31.15. Biological E. Limited
32. Global Dengue Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Dengue Treatment Market
34. Recent Developments In The Dengue Treatment Market
35. Dengue Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Dengue Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Dengue Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Dengue Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
